TORC: Long $3.73 Price Target, $25 Potential

I own stock in TORC, and everything I say shouldn't be taken at face value. That being said, I do think realistically, TORC had a really negative run after its IPO, but it is in the process of doing clinical trials for really advanced aging diseases such as Parkinson's. The fact that it is a biopharmaceutical stock makes the price crash not too alarming giving the volatility of its market segmentation. I think realistically for a high risk, but still conservative short I can see a $3.73 price target happening within few years. What is even more bullish is that, if they finish their current clinical trials, and get further testing approvals, this can bring the price target even as high as $25. There are still many unknowns, so it is risky, but I am interested to see how this plays out.